These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8905799)

  • 1. [The relationship between single-oral dose kinetics of alprazolam and cytochrome P4503A and cytochrome P4502C19].
    Yasui N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):109-12. PubMed ID: 8905799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
    Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T
    Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam.
    Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Hayashi K; Chiba K; Ishizaki T
    Neuropsychopharmacology; 1997 Jan; 16(1):8-14. PubMed ID: 8981384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
    Masica AL; Mayo G; Wilkinson GR
    Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alprazolam-ritonavir interaction: implications for product labeling.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Durol AL; Daily JP; Graf JA; Mertzanis P; Hoffman JL; Shader RI
    Clin Pharmacol Ther; 2000 Apr; 67(4):335-41. PubMed ID: 10801241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily.
    Gorski JC; Jones DR; Hamman MA; Wrighton SA; Hall SD
    Xenobiotica; 1999 Sep; 29(9):931-44. PubMed ID: 10548453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation.
    Ishizaki T; Chiba K; Manabe K; Koyama E; Hayashi M; Yasuda S; Horai Y; Tomono Y; Yamato C; Toyoki T
    Clin Pharmacol Ther; 1995 Aug; 58(2):155-64. PubMed ID: 7648765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
    Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CYP3A inhibition on vesnarinone metabolism in humans.
    Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ
    Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam.
    Furukori H; Otani K; Yasui N; Kondo T; Kaneko S; Shimoyama R; Ohkubo T; Nagasaki T; Sugawara K
    Neuropsychopharmacology; 1998 May; 18(5):364-9. PubMed ID: 9536449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of CYP3A inhibition on the metabolism of cilostazol.
    Suri A; Forbes WP; Bramer SL
    Clin Pharmacokinet; 1999; 37 Suppl 2():61-8. PubMed ID: 10702888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of alpha- and 4-hydroxy metabolites in healthy subjects.
    Wennerholm A; Allqvist A; Svensson JO; Gustafsson LL; Mirghani RA; Bertilsson L
    Eur J Clin Pharmacol; 2005 Apr; 61(2):113-8. PubMed ID: 15806426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases.
    Jung F; Richardson TH; Raucy JL; Johnson EF
    Drug Metab Dispos; 1997 Feb; 25(2):133-9. PubMed ID: 9029042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A).
    Yasumori T; Chen L; Nagata K; Yamazoe Y; Kato R
    J Pharmacol Exp Ther; 1993 Jan; 264(1):89-94. PubMed ID: 8423554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics and pharmacodynamics of oral triazolam in relation to cytochrome P4502C19 (CYP2C19) activity.
    Yasui N; Otani K; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T; Kaneko S
    Ther Drug Monit; 1997 Aug; 19(4):371-4. PubMed ID: 9263374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of estazolam.
    Otsuji Y; Okuyama N; Aoshima T; Fukasawa T; Kato K; Gerstenberg G; Miura M; Ohkubo T; Sugawara K; Otani K
    Ther Drug Monit; 2002 Jun; 24(3):375-8. PubMed ID: 12021628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response evaluation of the interaction between sertraline and alprazolam in vivo.
    Hassan PC; Sproule BA; Naranjo CA; Herrmann N
    J Clin Psychopharmacol; 2000 Apr; 20(2):150-8. PubMed ID: 10770452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: a panel study.
    Gram LF; Guentert TW; Grange S; Vistisen K; Brøsen K
    Clin Pharmacol Ther; 1995 Jun; 57(6):670-7. PubMed ID: 7781267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CYP3A4 inhibition by diltiazem on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status.
    Kosuge K; Jun Y; Watanabe H; Kimura M; Nishimoto M; Ishizaki T; Ohashi K
    Drug Metab Dispos; 2001 Oct; 29(10):1284-9. PubMed ID: 11560871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.